Mindmed to participate in june conferences

New york--(business wire)---- $mnmd--mind medicine (mindmed) inc. (nasdaq: mnmd) (the “company” or “mindmed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that members of the company's management team will participate in the following conferences: bio international convention 2024 panel name: challenging biotech's one-track mind when it comes to neuropsychiatric drug innovation date and time: tuesday, june 4, 2024 at 4:15.
MNMD Ratings Summary
MNMD Quant Ranking